New book by Larry Connors Click here Improve your trading - See how
Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company has long been renowned for its medical imaging systems, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), mammography, angiography, ultrasound and molecular imaging (MI) products, as well as related computer-based workstations, healthcare IT systems, oncology care products and hearing aids. Siemens also has a share in DrAnger Medical, a leader in the market for electromedical systems, including patient monitoring products and electrophysiological measuring systems.
Over the last few years, Siemens has expanded its medical portfolio through targeted acquisitions. By acquiring Shared Medical Systems (healthcare IT) in 2000, CTI Molecular Imaging in 2005, Diagnostic Products Corporation (DPC) and Bayer Diagnostics in 2006, and Dade Behring in 2007, Siemens has created the world's first and only fully-integrated diagnostics company, combining imaging diagnostics, laboratory diagnostics and clinical IT under one roof. As a result, Siemens Healthcare now delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care.
The company employs more than 49,000 people worldwide and operates in 130 countries. In fiscal 2007, Siemens Healthcare reported sales of EUR 9.85 billion, orders of EUR 10.27 billion, and group profit of EUR 1.32 billion.
The acquisitions of DPC, Bayer Diagnostics and, most recently, Dade Behring, have also doubled the overall market served by Siemens' Healthcare sector to EUR 57 billion and given the group access to further attractive market segments. As a result, Siemens has raised its Healthcare sector's target margin range to 14 -- 17%.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review.
Key Topics Covered: - Overview - Strategic Focus - Products - Research and Development - International Activities - Financial Indicators - Key Corporate Events - Mergers & Acquisitions - Joint Ventures - Minority Investments - Divestitures - Agreements - Litigation Companies Mentioned: -Biosense Webster -Stereotaxis -SonoSite -IMRIS -Cleveland Clinic -HearUSA -Vocera Communications -Fuji -Agfa-Gevaert -EMC Corporation -Invivo Corporation (Philips) -RxHub -DatCard Systems -Elekta -3M -Hightech Electronic GmbH -SAP AG -Cincinnati Children's Hospital Medical Center -NextGen Healthcare Information Systems -Zynx Health -HP -Vital Images -CMS -IBM -HiPGraphics -iCAD -TechSmith -Toshiba Medical Systems -Millennium Solutions -BSD Medical -GlaxoSmithKline -Anceta -U-Systems -Merck -StorageTek -Oxford Instruments -Molecular Imaging Corporation. -TomTec Imaging Systems -eResearch Technology -i3ARCHIVE -Medrad -Air Products -Eastman Kodak -Terason -Research Systems -Astraia Software -Sigaba -Medtronic -Hologic -Research Corporation Technologies -BrainLAB -Staffware -Hitachi Medical -Health Patterns -Cassling Diagnostic Imaging -Global Med Technologies' Wyndgate Technologies Division -Bruker Medical -Pegasus Imaging -Matsushita Electric Industrial Co Ltd -Analogic -Civco Medical Solutions (Roper Industries) -Siemens' Diagnostics Agreements -Bio-Rad Laboratories -Mubadala Development -Medical University of South Carolina -University of Muenster -Barts and Royal London Hospitals -Premier -Nova Southeastern University -Novation -HealthTrust Purchasing Group -Consorta -Trident Molecular Imaging -Alegent Health -Kaiser Permanente -Scripps
For more information visit http://www.researchandmarkets.com/research/5a0857/siemens_healthcare
Source: Espicom Business Intelligence Ltd
SOURCE: Research and Markets Ltd.
Research and Markets Laura Wood, Senior Manager U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 press@researchandmarkets.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
